Statistics for Anti-Ro52 Antibodies and Interstitial Lung Disease in ConnectiveTissue Diseases Excluding Scleroderma
Total visits
| views | |
|---|---|
| Anti-Ro52 Antibodies and Interstitial Lung Disease in ConnectiveTissue Diseases Excluding Scleroderma | 721 |
Total visits per month
| views | |
|---|---|
| December 2024 | 0 |
| January 2025 | 1 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
| June 2025 | 0 |
File Visits
| views | |
|---|---|
| clinical study.ro52[1].pdf(legacy) | 895 |
| clinical study.ro52[1].pdf | 2 |
| pdf 1.2 .pdf(legacy) | 1 |
Top country views
| views | |
|---|---|
| Portugal | 324 |
| United States | 217 |
| China | 31 |
| Russia | 30 |
| Germany | 20 |
| Poland | 17 |
| France | 14 |
| Brazil | 9 |
| United Kingdom | 9 |
| Netherlands | 4 |
| Canada | 3 |
| Ireland | 3 |
| Singapore | 3 |
| Turkey | 3 |
| Ukraine | 3 |
| Australia | 2 |
| Iran | 2 |
| Italy | 2 |
| Japan | 2 |
| Argentina | 1 |
| Chile | 1 |
| Colombia | 1 |
| Denmark | 1 |
| Norway | 1 |
Top city views
| views | |
|---|---|
| Lisbon | 1 |